Oncolytic Virus Therapy Market Technology, Product Scope, Demand, Business Scenario, Trends, Share, Applications, Types and Forecasts 2020 – 2028

by Emergen Research · December 16, 2021

oncolytic virus therapy market size is expected to reach USD 866.1 Million at a steady CAGR of 23.9% in 2028, according to latest analysis by Emergen Research. Steady growth of oncolytic virus therapy market can be attributed to rising cancer incidence globally. Cancer is a major cause of deaths in countries across the globe and it is estimated that in 2020, over 1.8 million new cancer cases were diagnosed in the US, with over 0.6 Million deaths occurring due to the disease. Also, around 70% of cancer mortality occurs in low and middle-income countries. Oncolytic virus therapy (a type of immunotherapy) uses engineered viruses to destroy cancer cells without affecting healthy cells in the human body. Once a cancer cell is destroyed, it releases cancer antigens that trigger immune responses to destroy other tumor cells in the body.

Global Oncolytic Virus Therapy Market that provides an extensive analysis of the Oncolytic Virus Therapy market and industry overview with regards to market size, market share, revenue growth, key companies, current and emerging market trends, recent technological and product developments, and a comprehensive analysis of the impact of COVID-19 pandemic on the growth of the Oncolytic Virus Therapy market. The report aims to offer a clear understanding of the market with respect to the manufacturers, suppliers, vendors, distributors, and key companies involved in the market. The report has been formulated through extensive primary and secondary research along with verified and reliable data obtained from industry experts and professionals. The key findings from the report have been sorted into charts, figures, tables, and other pictorial representations.

Get a sample of the report @ https://www.emergenresearch.com/request-sample/541

The global Oncolytic Virus Therapy market is expected to reach USD 866.1 Million in 2028 from its valuation of USD 154.5 Million in 2020 at a CAGR of 23.9% during the forecast period. Rapid technological advancements and economic growth are key factors expected to drive market growth over the forecast period. The report further provides a comprehensive analysis of the competitive landscape and provides a complete coverage with regards to company’s profiles, product portfolio, revenue generation, financial standing and market position.

Top Companies Operating in the Oncolytic Virus Therapy Market and Profiled in the Report are:

Oncolytics Biotech Inc., Lokon Pharma AB, PsiOxus Therapeutics, Sorrento Therapeutics Inc., CG Oncology Inc., ORYX GmbH & Co. KG, VCNBiosciences, DNAtrix, Targovax, and SillaJen Inc.

It further offers a comprehensive coverage of the strategic alliances such as mergers and acquisitions, joint ventures, collaborations, product launches, brand promotions, and partnerships, among others. Key strategic alliances for product development and advancements is expected to add traction to market growth going ahead. The report also covers an in-depth analysis of the key competitors of the market along with their growth strategies and business expansion plans.

Regional analysis of the Oncolytic Virus Therapy market includes analysis of the production and consumption ratio, supply and demand dynamics, regional trends and growth drivers, growth prospects, presence of key manufacturers and vendors, and market size and share in key regions such as North America, Latin America, Europe, Asia Pacific, and Middle East and Africa. The report further offers key insights into country wise analysis and major factors driving revenue growth of each regional market.

Request a customization of the report @ https://www.emergenresearch.com/request-for-customization/541

Detailed Regional Analysis Covers:

North America
- Canada
- S.
- Mexico
Europe
- Germany
- Italy
- K.
- Rest of EU
Asia Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Latin America
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa
- Saudi Arabia
- South Africa
- A.E
- Rest of MEA

Emergen Research has segmented the global oncolytic virus therapy market on the basis of type, application, end-use, and region:

Type Outlook (Revenue, USD Million; 2021–2028)
- Monoclonal Antibodies
- Checkpoint Inhibitors
- Cancer Vaccines
- Immunomodulators
Application Outlook (Revenue, USD Million; 2021–2028)
- Melanoma
- Lung Cancer
- Breast Cancer
- Others
End-Use Outlook (Revenue, USD Million; 2021–2028)
- Hospitals
- Clinics
- Research Institutes
- Others